Is atorvastatin safe to take
Pro Research Analysisby 
Searched over 200M research papers
Safety of Atorvastatin: A Comprehensive Review
Introduction to Atorvastatin Safety
Atorvastatin, a widely used statin, is primarily prescribed for the prevention of cardiovascular events. Its safety and tolerability are crucial, given its extensive use across various patient populations, including the elderly, those with chronic kidney disease, and diabetic patients 1.
General Safety and Tolerability
Incidence of Adverse Events
Multiple studies have demonstrated that atorvastatin is generally well tolerated across its therapeutic dosage range (10-80 mg/day). In a comprehensive analysis of 44 trials involving 9,416 patients treated with atorvastatin, only 3% withdrew due to treatment-associated adverse events, which is comparable to the withdrawal rates for placebo and other statins 2. Similarly, a meta-analysis of 17 randomized controlled trials involving 21,910 participants confirmed that atorvastatin 80 mg/day is less tolerable compared to controls but still maintains a favorable safety profile 8.
Common Adverse Events
The most frequently reported adverse events associated with atorvastatin are related to the digestive system, such as constipation, flatulence, dyspepsia, and abdominal pain 9. Headache and nausea were also common but occurred at similar rates to placebo 7.
Specific Adverse Events
Hepatic and Musculoskeletal Effects
Persistent elevations in hepatic transaminases (>3 times the upper limit of normal) were observed in a small percentage of patients (0.5% in one study) 2. However, these elevations did not typically lead to clinically significant adverse events 4. Musculoskeletal side effects, such as myalgia, were reported at low rates (1.9% for atorvastatin vs. 0.8% for placebo) and were not dose-dependent 2. Importantly, no cases of rhabdomyolysis or myopathy were reported in the analyzed studies 23.
Safety in High Doses
Atorvastatin 80 mg/day has been scrutinized for its safety. While it is associated with a higher incidence of liver enzyme elevations, these do not appear to result in significant clinical issues 4. The incidence of creatine kinase elevation and myalgia was not significantly different from placebo, and no cases of rhabdomyolysis were reported 8.
Special Populations
Elderly and Renal Dysfunction
Atorvastatin is well tolerated in patients aged 65 and older, with no dose-dependent increase in adverse events up to 80 mg/day 4. Additionally, it does not require dosage adjustment in patients with renal dysfunction due to its favorable pharmacokinetic profile 4.
Pediatric Use
In children and adolescents with familial hypercholesterolemia or severe hyperlipidemia, atorvastatin (10-20 mg) was found to be both effective and well-tolerated over a 12-month period 510. The safety profile in this population was comparable to that of placebo, with no significant adverse events reported.
Burn Patients
A study on burn patients receiving atorvastatin found no adverse events or lab abnormalities attributable to the drug, suggesting its safety in this specific patient group 6.
Conclusion
Overall, atorvastatin is a safe and well-tolerated statin across a wide range of dosages and patient populations. While there are some concerns regarding hepatic enzyme elevations and musculoskeletal side effects, these are generally infrequent and not clinically significant. The drug's safety profile supports its widespread use in both general and special populations, including the elderly, those with renal dysfunction, and pediatric patients.
Sources and full results
Most relevant research papers on this topic